학술논문
Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study
Document Type
Article
Author
Cortot, A.B.; Audigier-Valette, C.; Molinier, O.; Le Moulec, S.; Barlesi, F.; Zalcman, G.; Dumont, P.; Pouessel, D.; Poulet, C.; Fontaine-Delaruelle, C.; Hiret, S.; Dixmier, A.; Renault, P.-A.; Becht, C.; Raffy, O.; Dayen, C.; Mazieres, J.; Pichon, E.; Langlais, A.; Morin, F.; Moro-Sibilot, D.; Besse, B.
Source
In: European Journal of Cancer . (European Journal of Cancer, May 2020, 131:27-36)
Subject
Language
English
ISSN
18790852
09598049
09598049